Furthermore, the results from the IF assay suggested that, in addition to its inhibitory effect on p-FAK expression, flavokawain C treatment influenced the distribution of FAK in liver cancer Huh-7 and Hep3B cells (Fig. 8I). Here, PTK2 is linked to liver cancer.